Palisade Bio, Inc. SEC filings PALI

Palisade Bio, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Nov 16, 2011. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 10, 2026 (results of operations). The company's fiscal year ends on December 31.

Palisade Bio, Inc. SEC filings
Form Description Filed Period
S-8 Employee stock plan registration Jun 10, 2026 —
S-3 Shelf registration May 12, 2026 —
S-8 Employee stock plan registration Nov 12, 2025 —
424B4 Prospectus Oct 2, 2025 —
S-1MEF Filing Oct 1, 2025 —
S-1 Registration statement Sep 29, 2025 —
S-3 Shelf registration Aug 15, 2025 —
S-1 Registration statement May 27, 2025 —
424B3 Prospectus Dec 17, 2024 —
424B3 Prospectus Dec 17, 2024 —
424B3 Prospectus Dec 17, 2024 —
424B5 Prospectus supplement Dec 13, 2024 —
POS AM Filing Dec 13, 2024 —
S-1/A Amended registration statement Dec 9, 2024 —
S-1/A Amended registration statement Dec 5, 2024 —
FWP Free writing prospectus Nov 22, 2024 —
S-1/A Amended registration statement Nov 21, 2024 —
S-1 Registration statement Oct 30, 2024 —
424B3 Prospectus May 17, 2024 —
S-3 Shelf registration May 8, 2024 —
424B3 Prospectus Apr 5, 2024 —
S-3 Shelf registration Mar 29, 2024 —
S-8 Employee stock plan registration Mar 29, 2024 —
424B3 Prospectus Feb 1, 2024 —
424B3 Prospectus Feb 1, 2024 —
424B3 Prospectus Feb 1, 2024 —
424B3 Prospectus Feb 1, 2024 —
S-1 Registration statement Dec 29, 2023 —
S-8 Employee stock plan registration Sep 14, 2023 —
424B5 Prospectus supplement Sep 11, 2023 —
424B3 Prospectus Apr 27, 2023 —
S-1/A Amended registration statement Apr 27, 2023 —
S-1 Registration statement Apr 21, 2023 —
424B5 Prospectus supplement Apr 5, 2023 —
424B3 Prospectus Jan 24, 2023 —
S-1 Registration statement Jan 13, 2023 —
424B5 Prospectus supplement Jan 4, 2023 —
424B4 Prospectus Aug 12, 2022 —
S-1MEF Filing Aug 11, 2022 —
S-1/A Amended registration statement Aug 11, 2022 —
S-1/A Amended registration statement Aug 10, 2022 —
S-1/A Amended registration statement Aug 9, 2022 —
S-1/A Amended registration statement Aug 2, 2022 —
424B3 Prospectus Jul 29, 2022 —
FWP Free writing prospectus Jul 25, 2022 —
S-1/A Amended registration statement Jul 22, 2022 —
424B3 Prospectus Jul 5, 2022 —
424B3 Prospectus Jun 29, 2022 —
S-1/A Amended registration statement Jun 22, 2022 —
S-1 Registration statement Jun 22, 2022 —
S-1 Registration statement Jun 14, 2022 —
424B5 Prospectus supplement Jun 8, 2022 —
424B5 Prospectus supplement May 6, 2022 —
424B3 Prospectus May 2, 2022 —
S-3/A Filing Apr 26, 2022 —
S-3/A Filing Apr 26, 2022 —
S-3 Shelf registration Mar 18, 2022 —
S-8 Employee stock plan registration Mar 18, 2022 —
S-3 Shelf registration Mar 18, 2022 —
424B3 Prospectus Dec 8, 2021 —
S-8 Employee stock plan registration Nov 19, 2021 —
S-3/A Filing Nov 19, 2021 —
S-3 Shelf registration Sep 23, 2021 —
S-8 Employee stock plan registration Sep 15, 2021 —
424B3 Prospectus Aug 10, 2021 —
S-3 Shelf registration Jul 30, 2021 —
424B3 Prospectus Feb 11, 2021 —
S-4/A Filing Feb 9, 2021 —
S-4/A Filing Jan 26, 2021 —
S-4 Registration for a merger or exchange Dec 23, 2020 —
424B3 Prospectus Sep 28, 2020 —
S-3 Shelf registration Sep 16, 2020 —
424B5 Prospectus supplement May 27, 2020 —
424B3 Prospectus Apr 6, 2020 —
S-3/A Form s-3/a Mar 27, 2020 —
S-3 Shelf registration Feb 20, 2020 —
424B3 Prospectus Jan 22, 2020 —
424B4 Prospectus Jul 29, 2019 —
S-1/A Amended registration statement Jul 25, 2019 —
S-1/A Amended registration statement Jul 24, 2019 —
FWP Free writing prospectus Jul 22, 2019 —
S-1/A Amended registration statement Jul 22, 2019 —
S-1 Registration statement Jun 21, 2019 —
424B5 Prospectus supplement Oct 29, 2018 —
S-8 Employee stock plan registration Oct 4, 2017 —
424B5 Prospectus supplement Jul 28, 2017 —
424B5 Prospectus supplement Jul 26, 2017 —
424B3 Prospectus Jul 18, 2017 —
S-3/A Form s-3/a Jul 13, 2017 —
S-3 Shelf registration Jul 7, 2017 —
424B5 Prospectus supplement Jun 26, 2017 —
424B2 Prospectus Jun 26, 2017 —
S-3/A Form s-3/a Jun 21, 2017 —
S-3 Shelf registration Jun 8, 2017 —
424B5 Prospectus supplement May 4, 2016 —
424B5 Prospectus supplement May 2, 2016 —
424B3 Prospectus Feb 2, 2015 —
424B5 Prospectus supplement Jan 30, 2015 —
S-3 Shelf registration Jun 6, 2014 —
424B3 Prospectus Jun 2, 2014 —
S-8 Employee stock plan registration Mar 28, 2014 —
424B3 Prospectus Jan 15, 2014 —
424B5 Prospectus supplement Jan 6, 2014 —
424B5 Prospectus supplement Oct 25, 2013 —
424B3 Prospectus Sep 19, 2013 —
S-3/A Amendment to s-3 Sep 13, 2013 —
424B5 Prospectus supplement Sep 10, 2013 —
424B5 Prospectus supplement Sep 6, 2013 —
S-3 Shelf registration Aug 30, 2013 —
424B3 Prospectus Jul 11, 2013 —
424B3 Prospectus Jun 4, 2013 —
S-3 Shelf registration May 24, 2013 —
424B3 Prospectus May 24, 2013 —
424B3 Prospectus May 24, 2013 —
424B3 Prospectus May 6, 2013 —
424B3 Prospectus Feb 1, 2013 —
424B3 Prospectus Jan 15, 2013 —
424B5 Prospectus supplement Sep 14, 2012 —
424B5 Prospectus supplement Aug 15, 2012 —
FWP Free writing prospectus Aug 8, 2012 —
424B5 Prospectus supplement Aug 3, 2012 —
424B5 Prospectus supplement Feb 6, 2012 —

Showing 122 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
PALI (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Carlsbad, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1357459
Former names
PALISADE BIO, INC. (until Oct 30, 2026); Seneca Biopharma, Inc. (until Apr 26, 2021); Neuralstem, Inc. (until Jan 23, 2020)

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.